APA Zitierstil

AOKI, T., ARAKAWA, Y., UEBA, T., ODA, M., NISHIDA, N., AKIYAMA, Y., . . . MIYAMOTO, S. (2017). Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group. Neurol Med Chir (Tokyo).

Chicago Zitierstil

AOKI, Tomokazu, et al. "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group." Neurol Med Chir (Tokyo) 2017.

MLA Zitierstil

AOKI, Tomokazu, et al. "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group." Neurol Med Chir (Tokyo) 2017.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.